hims compounded semaglutide review cancels plans to sell GLP-1 pill after FDA backlash Hims & Hers falls 8%

The discontinuation rates due to adverse events, which were comparable to placebo, suggest that the transition to oral orforglipron is generally well-tolerated by patients already acclimated to incretin therapy

Lane 2 is biomimetic GLP-1 supplements (eg: yeast-delivered peptides)

Compounded semaglutide is not

Smaller players are far behind leaders like Novo and Lilly, said Evan Seigerman, managing director and senior research analyst at BMO Capital Markets

Lab ordering supports safety checks and helps identify metabolic risks

Semaglutide weight loss helps patients feel full longer, eat smaller portions, and reduce cravings